DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0090-9556/04/3202-272-279$20.00
DMD 32:272-279, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nikolic, D.
Right arrow Articles by van Breemen, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nikolic, D.
Right arrow Articles by van Breemen, R. B.

METABOLISM OF 8-PRENYLNARINGENIN, A POTENT PHYTOESTROGEN FROM HOPS (HUMULUS LUPULUS), BY HUMAN LIVER MICROSOMES

Dejan Nikolic, Yongmei Li, Lucas R. Chadwick, Simonida Grubjesic, Pia Schwab, Peter Metz, and Richard B. van Breemen

Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research, College of Pharmacy (D.N., Y.L., L.R.C., R.B.v.B.) and Department of Chemistry (S.G.), University of Illinois at Chicago, Chicago, Illinois; and Institut für Organische Chemie, Technische Universität Dresden, Dresden, Germany (P.S., P.M.)

The female flowers of hops are used throughout the world as a flavoring agent for beer. Recently, there has been increasing interest in the potential estrogenic properties of hop extracts. Among the possible estrogenic compounds in hops, 8-prenylnaringenin is perhaps most significant due to its high in vitro potency exceeding that of other known phytoestrogens. Since data regarding the pharmacokinetic properties of this compound are lacking, we investigated the in vitro metabolism of 8-prenylnaringenin by human liver microsomes. A total of 12 metabolites were identified, and biotransformation occurred on the prenyl group and the flavanone skeleton. The major site of oxidation was on the terminal methyl groups, and of the two possible isomers, thetransisomer was more abundant. The double bond on the prenyl group was also oxidized to an epoxide that was opened by intramolecular reaction with the neighboring hydroxyl group. On the flavanone skeleton, the major site of oxidation was at 3'position on the B ring. Other metabolites included oxidation at carbon-3 as well as desaturation of the C ring to produce 8-prenylapigenin. An unusual hydroxy quinone product formed byipsohydroxylation of the B ring of 8-prenylnaringenin was also detected. This product was probably an intermediate for the B ring cleavage product, 8-prenylchromone.


Address correspondence to: Richard B. van Breemen, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, 833 S. Wood St., Chicago, IL 60612-7231. E-mail: breemen{at}uic.edu




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
K. Minato, R. Suzuki, A. Asagarasu, T. Matsui, and M. Sato
Biotransformation of 3-Amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878), a Novel 5-Hydroxytryptamine (5-HT)1A Agonist/5-HT3 Antagonist, in Human Hepatic Cytochrome P450 Enzymes
Drug Metab. Dispos., May 1, 2008; 36(5): 831 - 840.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Guo, D. Nikolic, L. R. Chadwick, G. F. Pauli, and R. B. van Breemen
IDENTIFICATION OF HUMAN HEPATIC CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 8-PRENYLNARINGENIN AND ISOXANTHOHUMOL FROM HOPS (HUMULUS LUPULUS L.)
Drug Metab. Dispos., July 1, 2006; 34(7): 1152 - 1159.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. Nikolic and R. B. van Breemen
NEW METABOLIC PATHWAYS FOR FLAVANONES CATALYZED BY RAT LIVER MICROSOMES
Drug Metab. Dispos., April 1, 2004; 32(4): 387 - 397.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.